These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 21567106)
1. Autocrine human growth hormone reduces mammary and endometrial carcinoma cell sensitivity to mitomycin C. Bougen NM; Yang T; Chen H; Lobie PE; Perry JK Oncol Rep; 2011 Aug; 26(2):487-93. PubMed ID: 21567106 [TBL] [Abstract][Full Text] [Related]
2. Autocrine human GH promotes radioresistance in mammary and endometrial carcinoma cells. Bougen NM; Steiner M; Pertziger M; Banerjee A; Brunet-Dunand SE; Zhu T; Lobie PE; Perry JK Endocr Relat Cancer; 2012 Oct; 19(5):625-44. PubMed ID: 22807498 [TBL] [Abstract][Full Text] [Related]
3. Oncogenic transformation of human mammary epithelial cells by autocrine human growth hormone. Zhu T; Starling-Emerald B; Zhang X; Lee KO; Gluckman PD; Mertani HC; Lobie PE Cancer Res; 2005 Jan; 65(1):317-24. PubMed ID: 15665309 [TBL] [Abstract][Full Text] [Related]
4. Phenotypic conversion of human mammary carcinoma cells by autocrine human growth hormone. Mukhina S; Mertani HC; Guo K; Lee KO; Gluckman PD; Lobie PE Proc Natl Acad Sci U S A; 2004 Oct; 101(42):15166-71. PubMed ID: 15353581 [TBL] [Abstract][Full Text] [Related]
5. Autocrine human growth hormone increases sensitivity of mammary carcinoma cell to arsenic trioxide-induced apoptosis. Zekri A; Ghaffari SH; Yousefi M; Ghanizadeh-Vesali S; Mojarrad M; Alimoghaddam K; Ghavamzadeh A Mol Cell Endocrinol; 2013 Sep; 377(1-2):84-92. PubMed ID: 23851143 [TBL] [Abstract][Full Text] [Related]
6. DNMT3A and DNMT3B mediate autocrine hGH repression of plakoglobin gene transcription and consequent phenotypic conversion of mammary carcinoma cells. Shafiei F; Rahnama F; Pawella L; Mitchell MD; Gluckman PD; Lobie PE Oncogene; 2008 Apr; 27(18):2602-12. PubMed ID: 17998942 [TBL] [Abstract][Full Text] [Related]
7. Autocrine human growth hormone promotes tumor angiogenesis in mammary carcinoma. Brunet-Dunand SE; Vouyovitch C; Araneda S; Pandey V; Vidal LJ; Print C; Mertani HC; Lobie PE; Perry JK Endocrinology; 2009 Mar; 150(3):1341-52. PubMed ID: 18974274 [TBL] [Abstract][Full Text] [Related]
8. Autocrine human growth hormone stimulates oncogenicity of endometrial carcinoma cells. Pandey V; Perry JK; Mohankumar KM; Kong XJ; Liu SM; Wu ZS; Mitchell MD; Zhu T; Lobie PE Endocrinology; 2008 Aug; 149(8):3909-19. PubMed ID: 18450952 [TBL] [Abstract][Full Text] [Related]
9. p44/42 MAP kinase-dependent regulation of catalase by autocrine human growth hormone protects human mammary carcinoma cells from oxidative stress-induced apoptosis. Zhu Z; Mukhina S; Zhu T; Mertani HC; Lee KO; Lobie PE Oncogene; 2005 May; 24(23):3774-85. PubMed ID: 15782123 [TBL] [Abstract][Full Text] [Related]
10. Tumor expression of human growth hormone and human prolactin predict a worse survival outcome in patients with mammary or endometrial carcinoma. Wu ZS; Yang K; Wan Y; Qian PX; Perry JK; Chiesa J; Mertani HC; Zhu T; Lobie PE J Clin Endocrinol Metab; 2011 Oct; 96(10):E1619-29. PubMed ID: 21849525 [TBL] [Abstract][Full Text] [Related]
11. Potentiation of apoptosis by flavopiridol in mitomycin-C-treated gastric and breast cancer cells. Schwartz GK; Farsi K; Maslak P; Kelsen DP; Spriggs D Clin Cancer Res; 1997 Sep; 3(9):1467-72. PubMed ID: 9815832 [TBL] [Abstract][Full Text] [Related]
12. Autocrine human growth hormone (hGH) regulation of human mammary carcinoma cell gene expression. Identification of CHOP as a mediator of hGH-stimulated human mammary carcinoma cell survival. Mertani HC; Zhu T; Goh EL; Lee KO; Morel G; Lobie PE J Biol Chem; 2001 Jun; 276(24):21464-75. PubMed ID: 11297545 [TBL] [Abstract][Full Text] [Related]
13. Autocrine stimulation of human mammary carcinoma cell proliferation by human growth hormone. Kaulsay KK; Mertani HC; Törnell J; Morel G; Lee KO; Lobie PE Exp Cell Res; 1999 Jul; 250(1):35-50. PubMed ID: 10388519 [TBL] [Abstract][Full Text] [Related]
14. Autocrine human growth hormone enhancement of human mammary carcinoma cell spreading is Jak2 dependent. Kaulsay KK; Mertani HC; Lee KO; Lobie PE Endocrinology; 2000 Apr; 141(4):1571-84. PubMed ID: 10746665 [TBL] [Abstract][Full Text] [Related]
15. Mode of the autocrine/paracrine mechanism of growth hormone action. Liu N; Mertani HC; Norstedt G; Törnell J; Lobie PE Exp Cell Res; 1997 Nov; 237(1):196-206. PubMed ID: 9417883 [TBL] [Abstract][Full Text] [Related]
16. A novel doxorubicin-mitomycin C co-encapsulated nanoparticle formulation exhibits anti-cancer synergy in multidrug resistant human breast cancer cells. Shuhendler AJ; Cheung RY; Manias J; Connor A; Rauth AM; Wu XY Breast Cancer Res Treat; 2010 Jan; 119(2):255-69. PubMed ID: 19221875 [TBL] [Abstract][Full Text] [Related]
17. Autocrine human growth hormone stimulates the tumor initiating capacity and metastasis of estrogen receptor-negative mammary carcinoma cells. Chen YJ; Zhang X; Wu ZS; Wang JJ; Lau AY; Zhu T; Lobie PE Cancer Lett; 2015 Sep; 365(2):182-9. PubMed ID: 26070963 [TBL] [Abstract][Full Text] [Related]
18. Gene expression profiling to identify oncogenic determinants of autocrine human growth hormone in human mammary carcinoma. Xu XQ; Emerald BS; Goh EL; Kannan N; Miller LD; Gluckman PD; Liu ET; Lobie PE J Biol Chem; 2005 Jun; 280(25):23987-4003. PubMed ID: 15845533 [TBL] [Abstract][Full Text] [Related]
19. Differential chemosensitivity of breast cancer cells to ganciclovir treatment following adenovirus-mediated herpes simplex virus thymidine kinase gene transfer. Li PX; Ngo D; Brade AM; Klamut HJ Cancer Gene Ther; 1999; 6(2):179-90. PubMed ID: 10195885 [TBL] [Abstract][Full Text] [Related]
20. Autocrine vascular endothelial growth factor signalling in breast cancer. Evidence from cell lines and primary breast cancer cultures in vitro. Weigand M; Hantel P; Kreienberg R; Waltenberger J Angiogenesis; 2005; 8(3):197-204. PubMed ID: 16328160 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]